Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sunshine Biopharma (SBFM) Equity Ratio (2016 - 2025)

Historic Equity Ratio for Sunshine Biopharma (SBFM) over the last 14 years, with Q3 2025 value amounting to 0.77.

  • Sunshine Biopharma's Equity Ratio fell 774.54% to 0.77 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.77, marking a year-over-year decrease of 774.54%. This contributed to the annual value of 0.77 for FY2024, which is 83.8% down from last year.
  • Sunshine Biopharma's Equity Ratio amounted to 0.77 in Q3 2025, which was down 774.54% from 0.8 recorded in Q2 2025.
  • Sunshine Biopharma's 5-year Equity Ratio high stood at 1.0 for Q2 2022, and its period low was 0.58 during Q1 2021.
  • Its 5-year average for Equity Ratio is 0.57, with a median of 0.78 in 2025.
  • Per our database at Business Quant, Sunshine Biopharma's Equity Ratio soared by 66970.33% in 2022 and then tumbled by 2750.1% in 2023.
  • Over the past 5 years, Sunshine Biopharma's Equity Ratio (Quarter) stood at 0.1 in 2021, then surged by 669.7% to 0.74 in 2022, then increased by 4.86% to 0.78 in 2023, then dropped by 0.84% to 0.77 in 2024, then decreased by 0.06% to 0.77 in 2025.
  • Its last three reported values are 0.77 in Q3 2025, 0.8 for Q2 2025, and 0.78 during Q1 2025.